3-(3-Formamidosalicylamido)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-ylisovalerat Produkt Beschreibung

CAS-Nr.	642-15-9
Bezeichnung:	3-(3-Formamidosalicylamido)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-ylisovalerat
Englisch Name:	ANTIMYCIN A1
Synonyma:	3-(3-Formamidosalicylamido)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-ylisovalerat ANTIMYCIN A1;dihydrosamidin;1,5-Dioxonane butanoic acid deriv.;-dioxo-1,5-dioxonan-3-yl)salicylamide;isovalericacid,8-esterwith3-formamido-n-(7-hexyl-8-hydroxy-4,9-dimethyl-2,6;3-(3-formamidosalicylamido)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl isovalerate;[3-[(3-formamido-2-hydroxybenzoyl)amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl] 3-methylbutanoate;[3-[(3-formamido-2-hydroxy-phenyl)carbonylamino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl] 3-methylbutanoate;3-methylbutyric acid [3-[(3-formamido-2-hydroxy-benzoyl)amino]-8-hexyl-4,9-diketo-2,6-dimethyl-1,5-dioxonan-7-yl] ester;3-Methylbutyric acid 3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester
CBNumber:	CB9479432
Summenformel:	C28H40N2O9
Molgewicht:	548.63
MOL-Datei:	642-15-9.mol

3-(3-Formamidosalicylamido)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-ylisovalerat physikalisch-chemischer Eigenschaften

Schmelzpunkt::

149.5℃

storage temp. :

−20°C

Sicherheit

Kennzeichnung gefährlicher:

R-Sätze::

23/24/25

S-Sätze::

36/37/39-45

RIDADR :

3172

RTECS-Nr.:

NY1503500

HazardClass :

6.1(a)

PackingGroup :

3-(3-Formamidosalicylamido)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-ylisovalerat Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden
Antimycin A1 is the most hydrophobic of the four analogues of the antimycin A complex. Like all antimycins, antimycin A1 exhibits potent antifungal, anthelmintic, insecticidal, antiviral and antitumor activity across a range of bioassays. Although broadly active as respiration inhibitors, more recent investigation has highlighted the importance of individual members of the complex as bioprobes. Antimycin A1 inhibits angiogenesis via a decrease in VEGF production caused by inhibition of HIF-1a activation.

R-Sätze Betriebsanweisung:
R23/24/25:Giftig beim Einatmen, Verschlucken und Berührung mit der Haut.

S-Sätze Betriebsanweisung:
S36/37/39:Bei der Arbeit geeignete Schutzkleidung,Schutzhandschuhe und Schutzbrille/Gesichtsschutz tragen.
S45:Bei Unfall oder Unwohlsein sofort Arzt zuziehen (wenn möglich, dieses Etikett vorzeigen).

3-(3-Formamidosalicylamido)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-ylisovalerat Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

3-(3-Formamidosalicylamido)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-ylisovalerat Anbieter Lieferant Produzent Hersteller Vertrieb Händler. Global( 17)Lieferanten

Firmenname	Telefon	Fax	E-Mail	Land	Produktkatalog	Edge Rate
ChemStrong Scientific Co.,Ltd	0755 66853366	0755 28363542	sales@chem-strong.com;	CHINA	11269	56

642-15-9(3-(3-Formamidosalicylamido)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-ylisovalerat)Verwandte Suche:

8-Butyl-3-(3-formamido-2-hydroxybenzamido)-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-ylbutyrat 8-Ethyl-3-(3-formamidosalicylamido)-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-ylisovalerat 3,4-Dihydro-8-hydroxy-3,4,5-trimethyl-6H-6-oxo-benzo(c)pyran-7-carbonsäure 8-Ethyl-3-[[3-(formylamino)salicyloyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-ylbutyrat Butylaminoacetathydrochlorid Isobutylisovalerat Octylisovalerat 3-Amino-N-(isopropyl)benzamid 3-[3-Formamidosalicylamido]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-ylbutyrat 3-(2-Ethylbutoxy)propionsure N-(2-Hydroxyethyl)salicylamid 2-Hydroxyhippursure 3-(3-Formamidosalicylamido)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-ylisovalerat

dihydrosamidin -dioxo-1,5-dioxonan-3-yl)salicylamide isovalericacid,8-esterwith3-formamido-n-(7-hexyl-8-hydroxy-4,9-dimethyl-2,6 ANTIMYCIN A1 642-15-9 3-(3-formamidosalicylamido)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl isovalerate C16H21NO2 C28H40N2O9 3-Methylbutanoic acid 3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester 3-Methylbutyric acid 3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester [3-[(3-formamido-2-hydroxybenzoyl)amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl] 3-methylbutanoate [3-[(3-formamido-2-hydroxy-phenyl)carbonylamino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl] 3-methylbutanoate 3-methylbutyric acid [3-[(3-formamido-2-hydroxy-benzoyl)amino]-8-hexyl-4,9-diketo-2,6-dimethyl-1,5-dioxonan-7-yl] ester 1,5-Dioxonane butanoic acid deriv.